Adverse Event Management
Dermatologic Adverse Events in Melanoma: What to Look Out For
BY BRITTANY COTE
Ovarian Suppression Plus AI Treatment Can Have Major Adverse Events
BY DAWN L. HERSHMAN, MD, MS
Nurse Offers Advice on Discussing AEs With Patients
BY KATHLEEN MADDEN, MSN, RN, APHN, AOCNP, FNP-BC
Managing irAEs is a Dynamic Discussion
BY BRIELLE BENYON AND GINA COLUMBUS
Luspatercept Reduces Anemia in Patients With MDS
BY BRITTANY COTE
Nurses: Frequently Discuss AEs With Your Patients
BY MADELINE KUIPER, MSN, RN, OCN
Patients' Opioid Self-Management Poses Risks
BY BRIELLE BENYON
FDA Accepts BLA for Eflapegrastim for Chemo-Induced Neutropenia
BY GINA COLUMBUS
AE Management Could Affect Compliance in Breast Cancer Treatment
BY MADELINE KUIPER, MSN, RN, OCN
Immunotherapy-Related Colitis: A 'Hot Topic'
BY YINGHONG WANG, MD, PHD, MS
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.